Form 4 for CNO CNO Financial Group, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-17 · accession 0001438233-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-18 | 2026-02-17+ | CNO | Zimpfer Matthew J. | GC | S - Sale+OE | $43.10 | -57.4K | 307.9K | -16% | -$2.47M |
| DM | 2026-02-18 | 2026-02-17+ | CNO | Zimpfer Matthew J. | GC | M - OptEx | $19.88 | +57.4K | 331.5K | +21% | +$1.14M |
| DM | 2026-02-18 | 2026-02-17+ | CNO | Zimpfer Matthew J. | GC | M - OptEx | $0.00 | -57.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | S | D | 23,570 | $43.17 | 307,937 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. (F2) Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 2 | Common | Common Stock | 2026-02-18 | M | A | 33,800 | $17.48 | 341,737 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-17 | M | A | 23,570 | $23.33 | 331,507 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-18 | S | D | 33,800 | $43.05 | 307,937 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. (F3) Reflects the weighted average sale price. Shares were sold at prices ranging from $42.92 per share to $43.28 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-18 | M | D | 33,800 | $0.00 | 0 | D | $17.48 · — to 2029-02-19 | 33,800 Common Stock | (F5) One-half of the stock options vested and became exercisable on February 19, 2021, and one-half vested and became exercisable on February 19, 2022. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-17 | M | D | 23,570 | $0.00 | 0 | D | $23.33 · — to 2028-02-21 | 23,570 Common Stock | (F4) One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021. |